Mathilda Davidson, a transactional IP partner, joined the firm from Gowling WLG today, January 6
This update includes a ruling from the Court of Appeal, a judgment of the Paris Local Division, news of upcoming hearings, and predictions for 2025
Practitioners reflect on the impact of USPTO guidance, as well as PTAB and litigation trends
Firms in Canada explain how they’ve adapted to a rule change in 2017 that has made advocacy skills more important in pharma disputes
In our latest UPC update, we examine an important decision concerning the withdrawal of opt-outs, a significant victory for Edwards, and the launch of a new Hamburg-based IP firm
Michael Sitzman, a life sciences litigator, explains how McDermott’s busy schedule at the UPC convinced him to join
In the latest UPC update, we examine a ruling on director liability, another on the Gillette defence, and look ahead to cases concerning medical devices
A&O Shearman’s co-heads of IP litigation say the addition of US partners post-merger ensures the firm is well poised to tap into the world’s major markets
In the latest UPC update, we review the NanoString and iMop rulings, a big move in London and a decision on whether a patent pool administrator can intervene
Benjamin Sodey, a former in-house lawyer at life sciences business MilliporeSigma, says he's looking forward to expanding his practice at Polsinelli
Vince Shier and Ryan Smith, who recently joined Brown Rudnick, say their new firm offers a strong platform to provide strategic advice
Hiroshi Sheraton will join the firm alongside a transactional specialist from Covington & Burling
Sponsored
Sponsored
-
Sponsored by LexOrbisManisha Singh and Pradeep Kumar Kamal of LexOrbis explain how India has adopted a unique solution to protecting the rights of plant breeders and farmers
-
Sponsored by Gün and PartnersAysel Korkmaz Yatkın and Fatma Sevde Tan of Gün and Partners discuss a welcome decision that reinforces patent owners’ right to information about pharmaceutical licensing applications in Turkey
-
Sponsored by Wanhuida Intellectual PropertyXiaohui Wu, Yuming Wang and Jianhui Li of Wanhuida Intellectual Property discuss the Supreme People’s Court’s first decision in parallel civil and administrative proceedings involving a chiral drug patent
Firms that advise generics businesses reflect on whether they’re seeing more aggressive tactics from innovators and how they’re managing their practices
Chad Landmon explains how he recruited a former life sciences litigation colleague to the firm and reveals one of the key clients that he brought over
Attorneys reveal how they navigate uncertainty in the CRISPR space and what developments they're watching
Jeffrey Morton, who moved to Haynes Boone in May, says he's excited about what the firm can do in San Diego as it looks to bolster its life sciences offering
Interviews; Exclusives
Interviews; Exclusives
Irena Royzman, who joined Orrick earlier this year, explains how she's collaborated with her new colleagues to address IP policy concerns
Paul Johns, IP litigation head for Pearce IP in New Zealand, discusses how the firm is becoming a truly trans-Tasman outfit by onboarding dual-qualified lawyers
Daphne Lainson discusses feeding cats at 4.30am and why Dolly Parton is an inspiration
Partners at Anderson Mori & Tomotsune say AI and the UPC are providing new business opportunities and reveal why flexibility is key to retaining talent
Procopio partner Jeremy Edwards explains how his team identified the best prior art when seeking to cancel a patent
Naomi Pearce of Pearce IP shares how she is helping her firm become a life sciences leader and how generous policies have helped attract top talent
-
Weekly take: Why the EU must press ahead with unitary SPCs
The EU should press ahead with plans to introduce a unitary SPC and the UPC and EUIPO should play leading roles, says Jörg Thomaier at Bayer -
Weekly take: IP-trade demands will fail future generations
The bedaquiline case highlights why tools such as India’s pre-grant opposition mechanism are so important -
Weekly take: No harm in senators exploring patent alternatives
A proposed study into delinkage may not amount to much, and must be backed by strong evidence, but it can’t hurt to look into the issue -
Opinion: Indian domestic policy must match WTO stand on IP waivers
India has been both urging for vaccine waivers before the WTO and refusing compulsory licensing in the country, but it’s not helping anyone